Prediction of janagliflozin pharmacokinetics in type 2 diabetes mellitus patients with liver cirrhosis or renal impairment using a physiologically based pharmacokinetic model-Reference-Cited by-同舟云学术

Prediction of janagliflozin pharmacokinetics in type 2 diabetes mellitus patients with liver cirrhosis or renal impairment using a physiologically based pharmacokinetic model

Published:2022-12 Issue: Volume:179 Page:106298
ISSN:0928-0987
Container-title:European Journal of Pharmaceutical Sciences
language:en
Short-container-title:European Journal of Pharmaceutical Sciences

Author:

Zhao Hengli,Wei Yilin,He Kun,Zhao Xiaoyu,Mu Hongli,Wen Qing^ORCID

Funder

National Major Science and Technology Projects of China

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference28 articles.

1. Liver cirrhosis;Barnett;Lancet,2018

2. Type 2 diabetes;Chatterjee;Lancet,2017

3. Screening early renal failure: cut-off values for serum creatinine as an indicator of renal impairment;Couchoud;Kidney Int.,1999

4. Increased intestinal permeability as a risk factor for type 2 diabetes;Cox;Diabetes Metab.,2017

5. Xenobiotic metabolism: the effect of acute kidney injury on non-renal drug clearance and hepatic drug metabolism;Dixon;Int. J. Mol. Sci.,2014

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Development and Application of a Physiologically Based Pharmacokinetic Model for Elagolix in the Adult and Adolescent Population;Clinical Pharmacokinetics;2024-07-26

2. Pharmacological Treatment of Diabetes Mellitus: An Overview of New Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Diabetes Mellitus;Journal of Endocrinology and Metabolism;2024-06

3. Electrochemical Lactonization Enabled by Unusual Shono-Type Oxidation from Functionalized Benzoic Acids;Organic Letters;2024-02-26

4. Chronic kidney disease and physiologically based pharmacokinetic modeling: a critical review of existing models;Expert Opinion on Drug Metabolism & Toxicology;2024-01-31

5. Effect of changes in metabolic enzymes and transporters on drug metabolism in the context of liver disease: Impact on pharmacokinetics and drug–drug interactions;British Journal of Clinical Pharmacology;2024-01-25